Synlett
DOI: 10.1055/a-2725-5792
Letter

Functionalized Diphenyl (2-oxochroman-4-yl)phosphonates: Dual Synthetic Approaches, Mechanistic Insights and Exploration of a Promising Anti-lung Cancerous Molecule

Authors

  • Indrajit Karmakar

    1   Chemistry, Visva-Bharati Siksha-Bhavana, Santiniketan, India (Ringgold ID: RIN449338)
  • Sudipa Chatterjee

    2   Department of Biotechnology, Visva-Bharati Institute of Science, Santiniketan, India (Ringgold ID: RIN449338)
  • Souvik Das

    3   Department of Chemistry, Visva-Bharati Institute of Science, Santiniketan, India (Ringgold ID: RIN449338)
  • Asanjan Brahmachari

    3   Department of Chemistry, Visva-Bharati Institute of Science, Santiniketan, India (Ringgold ID: RIN449338)
  • GourabKanti Das

    4   Chemistry, Visva-Bharati Institute of Science, Santiniketan, India (Ringgold ID: RIN449338)
  • Tathagata Choudhuri

    2   Department of Biotechnology, Visva-Bharati Institute of Science, Santiniketan, India (Ringgold ID: RIN449338)
  • Goutam Brahmachari

    4   Chemistry, Visva-Bharati Institute of Science, Santiniketan, India (Ringgold ID: RIN449338)

Supported by: Science and Engineering Research Board CRG/2022/000275
Supported by: Council of Scientific and Industrial Research 02/00464/23/EMR-II

We herein disclose a dual synthetic approach involving room temperature and mechanochemical strategies for a new series of substituted diphenyl (2-oxochroman-4-yl)phosphonates. Both methods offer a practical and straightforward synthetic route for such bio-relevant organophosphorus compounds. The salient features of both methods are the metal-free synthesis, mild and energy-efficient reaction conditions, good yields with high chemo- and regioselectivity, avoidance of column chromatographic purification, gram-scale synthetic applicability, and operational simplicity. The DFT study offers mechanistic insights into this transformation. Furthermore, the biological studies of the synthesized organophosphorus compounds explored their possible anticancerous profiles, and among the series, diphenyl (6-(tert-butyl)-2-oxochroman-4-yl)phosphonate (3c) exhibited anti-lung cancer activity in vitro. We herein emphasize that 3c might be considered for pre-clinical evaluation to establish its therapeutic relevance as an anti-cancer agent.



Publication History

Received: 08 August 2025

Accepted after revision: 16 October 2025

Accepted Manuscript online:
16 October 2025

© . Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany